Claritev Stock Price, News & Analysis

Claritev Corporation (NYSE: CTEV) is a healthcare technology, data and insights company in the U.S. healthcare system. The company describes its core focus as improving healthcare affordability, transparency and quality by using technology, artificial intelligence and large-scale claims data. Claritev is classified in the health information services and healthcare technology space and its Class A common stock trades on the New York Stock Exchange under the symbol CTEV.

According to multiple company disclosures, Claritev provides tech-enabled solutions and services that are fueled by multiple data sources and more than 40 years of claims repricing or claims processing experience. These solutions are delivered through an enterprise platform that uses AI and other technology to generate insights that aim to drive affordability in healthcare, bring price transparency, and optimize networks and benefits design. Claritev positions its offerings as purpose-built to support key stakeholders across the healthcare ecosystem, including payors, employers, patients, providers and third parties.

Business focus and role in healthcare

Claritev describes itself as a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all. The company highlights its use of world-class technology and AI solutions to power a robust enterprise platform. This platform is designed to analyze healthcare claims data and related information to identify potential medical cost savings, support price transparency, and inform network and benefit design decisions. In its public communications, Claritev also refers to its experience in payment integrity, network-based and analytics-based services, and to its role as a provider of technology-enabled cost management, payment and revenue integrity solutions to the U.S. healthcare industry.

Claritev reports that it serves a broad set of healthcare stakeholders. Across its disclosures, the company states that it serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers and 1.4 million contracted providers. These figures illustrate the scale at which its data and technology platform is applied within the healthcare system. Claritev also notes that it processes large volumes of claim charges and identifies potential medical cost savings based on that activity.

Stakeholders and market reach

The company emphasizes that its solutions are designed to support all key players in healthcare, explicitly naming payors, employers, patients, providers and third parties. Claritev’s communications describe a focus on helping these stakeholders access meaningful insights that can improve affordability and transparency. For payors and employers, this can include insights that inform benefit design and network optimization. For providers and other stakeholders, Claritev highlights the use of its data and analytics to support financial and administrative processes around claims, reimbursement and cost management.

Claritev has also described activities outside the U.S. In its news releases, the company refers to its international business and to strategic relationships aimed at delivering AI-powered revenue cycle management optimization and provider payment solutions in the Middle East and North Africa (MENA) region. Claritev has stated that its international business continues to expand and that it has secured exclusive rights to license, integrate and resell certain AI platforms in MENA, connecting that activity with its existing infrastructure and analytics capabilities.

Technology, data and AI platform

Across its press releases and descriptions, Claritev repeatedly highlights the role of AI and advanced analytics in its operations. The company states that it leverages world-class technology and AI solutions to power an enterprise platform that delivers meaningful insights to drive affordability in healthcare. It notes that its solutions and services are fueled by multiple data sources and decades of claims data, which are used to support claims analysis, pricing, and related decisions. Claritev also references specific technologies and platforms, such as its ACE (Advanced Code Editing) technology for claim coding intelligence, and its use of AI-powered tools to streamline financial and administrative processes for healthcare providers.

Claritev’s communications describe its platform as supporting claims analysis and payment-related decisions at scale. In one of its quarterly updates, the company reported that it processed tens of billions of dollars in claim charges in a single quarter and identified billions of dollars in potential medical cost savings. These disclosures underscore the scale of data processed by its systems and the role of analytics in identifying potential savings opportunities.

Customer base and ecosystem relationships

Claritev states that it serves more than 700 healthcare payors and over 100,000 employers, which indicates a broad presence among health plans and employer-sponsored benefit programs. The company also reports that its platform touches 60 million consumers and involves 1.4 million contracted providers. These figures, repeated across several press releases, suggest that Claritev’s technology and data services are integrated into a wide range of payer and provider relationships.

In addition to its direct relationships with payors and providers, Claritev has announced strategic agreements with other healthcare technology and fintech companies. For example, it has described a strategic relationship to deliver an AI-powered revenue cycle management platform in the MENA region and a strategic investment in a healthcare payment-acceleration solutions provider. In these announcements, Claritev links its existing analytics platforms and provider network with partners’ technologies to support claims management, payment acceleration and financial outcomes for healthcare organizations.

Corporate background and identity

Claritev has stated in its public communications that it was formerly known as MultiPlan. In these descriptions, the company presents the Claritev name as part of its identity as a healthcare technology, data and insights company focused on affordability, transparency and quality in the healthcare system. While detailed historical timelines are not provided in the supplied materials, the reference to more than 40 years of claims repricing or claims processing experience indicates a long operational history in healthcare claims and payment-related services.

Claritev is incorporated in Delaware and, according to its SEC filings, maintains its principal executive offices in McLean, Virginia. The company’s Class A common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and is listed on the New York Stock Exchange under the symbol CTEV. The filings also indicate that Claritev has issued Class A common stock with a par value of $0.0001 per share and that it uses common SEC reporting practices, including Form 8-K filings for material events and financial results.

Capital markets activity and investor communications

Claritev has been active in public capital markets and investor outreach. The company has reported that certain affiliates of Hellman & Friedman, identified as selling stockholders, conducted underwritten public offerings of Claritev’s Class A common stock. In these offerings, Claritev stated that it did not sell shares itself and did not receive proceeds from the sale of shares by the selling stockholders. The company also disclosed entering into an underwriting agreement with investment banks acting as joint-lead and additional bookrunners, and noted that the offering closed on a specified date.

Claritev regularly issues press releases and files Form 8-K reports to announce quarterly financial results, conference participation, contract renewals, and other corporate developments. The company has described its use of investor presentations and slide decks, made available through its website, as part of its Regulation FD-compliant communications. It has also announced participation in multiple healthcare and finance conferences hosted by financial institutions and has provided webcasts and audio archives of its presentations and earnings calls.

Financial reporting and non-GAAP metrics

Claritev provides detailed financial information in its earnings releases and SEC filings. In its quarterly results, the company reports revenues, net income or loss, and other financial metrics. Claritev also presents non-GAAP measures such as EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and an Adjusted cash conversion ratio. The company defines these terms in its disclosures and explains that they are supplemental measures used by management and, in its view, by investors and analysts to evaluate aspects of performance and cash generation.

In its explanations, Claritev notes that EBITDA represents net income or loss before interest expense, interest income, income tax provision or benefit, depreciation, amortization of intangible assets and non-income taxes. Adjusted EBITDA is described as EBITDA further adjusted by certain items. Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, while Unlevered Free Cash Flow adds back cash interest paid. The company also explains that its Adjusted cash conversion ratio is Unlevered Free Cash Flow divided by Adjusted EBITDA. Claritev cautions that these non-GAAP measures have limitations, are not a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies.

Client relationships and contracts

Claritev has disclosed information about its relationships with large clients. In one Form 8-K, the company reported that as of a specified date it had successfully renewed contracts with its ten largest clients, based on prior-year revenues, during the current year. It stated that these clients represented a significant portion of its total revenues and that, excluding clients with automatically renewing contracts, the weighted average contract term for this group was greater than three years. Claritev characterized these renewals as reinforcing its commitment to stability, growth and partnership with core clients, and linked them to its focus on improving affordability, transparency and quality by leveraging technology and AI solutions.

These disclosures indicate that Claritev’s revenue base is concentrated among a group of large clients, and that multi-year agreements and renewals are an important aspect of its business model. The company’s emphasis on contract renewals and long-term agreements suggests that it views client retention and extended relationships as central to its operations.

International initiatives and partnerships

Claritev’s news releases describe initiatives that extend its activities beyond the U.S. healthcare market. The company has announced a strategic agreement with iO Health-FZE to deliver an AI-powered platform, referred to as Optima AI, across the Middle East and North Africa region. Under this agreement, Claritev secured exclusive rights to license, integrate and resell the platform in MENA. The platform is described as a next-generation, AI-powered solution that helps streamline financial and administrative processes for healthcare providers, reduce claim denials, optimize workflows and improve financial outcomes.

Claritev has also announced a strategic investment in Klaim, Inc., which it describes as an AI-driven healthcare payment-acceleration solutions provider. The investment is intended to support the launch of a co-branded Payment Acceleration Service integrated within Claritev’s provider network, enabling healthcare organizations in the U.S. and MENA to gain faster and more predictable access to reimbursements. In connection with this collaboration, Claritev has stated that Klaim will leverage Claritev’s Advanced Code Editing (ACE) technology for claim coding intelligence to evaluate claims qualified for funding.

Branding and sponsorships

In addition to its core technology and data activities, Claritev has engaged in brand marketing initiatives. The company has announced golf sponsorships, including renewing an agreement with a professional golfer and signing new sponsorship agreements with additional professional golfers. Claritev describes these athletes as ambassadors who embody resilience, determination and excellence, and links the sponsorships to its mission of making healthcare more affordable, transparent and fair. These announcements illustrate how Claritev uses sports sponsorships as part of its brand positioning and public profile.

FAQs about Claritev Corporation

• What does Claritev Corporation do?
  Claritev Corporation is a healthcare technology, data and insights company focused on improving affordability, transparency and quality in the healthcare system. It provides tech-enabled solutions and services that use multiple data sources and decades of claims experience to support cost management, payment integrity, analytics and related functions for healthcare stakeholders.
• How does Claritev describe its technology platform?
  Claritev states that it utilizes world-class technology and AI solutions to power a robust enterprise platform. This platform is fueled by multiple data sources and more than 40 years of claims repricing or processing experience, and is designed to deliver meaningful insights that drive affordability, price transparency and optimized networks and benefits design.
• Who are Claritev’s key stakeholders and customers?
  The company reports that it serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers and 1.4 million contracted providers. Claritev emphasizes that its solutions are purpose-built to support payors, employers, patients, providers and third parties across the healthcare ecosystem.
• What is Claritev’s stock symbol and where is it listed?
  Claritev’s Class A common stock is listed on the New York Stock Exchange under the ticker symbol CTEV. The shares have a par value of $0.0001 per share, as disclosed in the company’s SEC filings.
• How does Claritev use artificial intelligence in its business?
  Claritev describes its use of AI to power its enterprise platform and to support solutions that analyze claims data, drive affordability and price transparency, and optimize networks and benefits design. It also references specific AI-powered tools and collaborations, such as Optima AI in the MENA region and the use of its ACE technology for claim coding intelligence in partnership with Klaim.
• What scale of activity does Claritev report in its claims processing?
  In one of its quarterly updates, Claritev reported processing approximately tens of billions of dollars in claim charges in a quarter and identifying billions of dollars in potential medical cost savings. These figures illustrate the scale at which its platform operates in analyzing claims and identifying potential savings opportunities.
• What non-GAAP financial measures does Claritev disclose?
  Claritev reports non-GAAP measures including EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and an Adjusted cash conversion ratio. The company defines these metrics in its disclosures and explains that they are supplemental to GAAP measures, with specific limitations and differences from standard accounting metrics.
• Has Claritev renewed contracts with its largest clients?
  Yes. In an 8-K filing, Claritev reported that as of a specified date it had successfully renewed contracts with its ten largest clients, based on prior-year revenues, during the current year. The company noted that these clients represented a significant portion of its total revenues and that the weighted average contract term for this group was greater than three years, excluding automatically renewing contracts.
• Does Claritev have international operations or partnerships?
  Claritev’s public communications refer to its international business and to strategic relationships in the Middle East and North Africa region. The company has announced an agreement to deliver an AI-powered platform for revenue cycle management in MENA and an investment in a payment-acceleration provider that supports activity across the U.S. and MENA regions.
• Was Claritev previously known by another name?
  Yes. In several news releases, Claritev is described as "formerly known as MultiPlan." These references link the Claritev name to a long history in healthcare claims and payment-related services, including more than 40 years of experience in claims repricing or processing.